Janssen Pharmaceutica Nv

Michael Moschetti

Jessica Lee

Jun Morimura

Marvin Quesada

John Vig

Andrew Thomson

Embodiments facilitate interoperability and secure determination of healthcare costs. An entity may receive a first Electronic Health Record (EHR) sub-block with patient medical coverage information and first treatments and may transmit a first Device Drug Information (DIR) sub-block comprising first treatment classes corresponding to each first treatment, first treatment class members corresponding to each first treatment class, and corresponding first treatment class member cost information. In response, the entity may receive a second EHR sub-block comprising second treatments each: associated with a corresponding first treatment, and selected from corresponding first treatment class members. Upon receipt of a transaction confirmation, the entity may augment a multi-dimensional blockchain with a multi-dimensional block formed by linking: a DIR block including second treatment information, an EHR block including information based on the second EHR sub-block and a transaction block. Payment assistance information determined from the second EHR block may be transmitted to a patient.

System and method for healthcare security and interoperability

Embodiments facilitate interoperability and secure patient selection for clinical trials and drug/device deployments. An entity may obtain a first set of health parameters and collective demographic information associated with one or more population segments and receive Electronic Health Record (EHR) sub-blocks with patient profile information and corresponding patient medical histories for patients. The entity may determine a subset of eligible candidate patients for a treatment based on information in the EHR sub-blocks and eligibility criteria for the treatment, which may be based the first set of health parameters, and/or the collective demographic information. The entity may transmit sub-blocks comprising eligible candidate patient profiles and medical information associated with the at least one treatment, and, in response to a received transaction block with a transaction confirmation, the entity may augment a multi-dimensional blockchain by linking: the transaction block, with a drug device information block and an EHR block.

Growing community of inventors

Montville, NJ, United States of America

Michael Moschetti